<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02472613</url>
  </required_header>
  <id_info>
    <org_study_id>201407001-6B</org_study_id>
    <nct_id>NCT02472613</nct_id>
  </id_info>
  <brief_title>Acupuncture for Ischemic Post-stroke Depression</brief_title>
  <official_title>Comparison of Acupuncture and Fluoxetine for of Ischemic Post-stroke Depression：A Multicentre Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Teaching Hospital of Tianjin University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>State Administration of Traditional Chinese Medicine of the People's Republic of China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin Academy of Tradional Chinese Medicine Afflicated Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Hospital of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>First Teaching Hospital of Tianjin University of Traditional Chinese Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicentre, single Blind ,randomized controlled clinical trial in ischemic
      post-stroke depression patients.The participants will be allocated randomly in either of the
      two groups: verum acupuncture plus placebo medication group or sham acupuncture plus true
      medication group. On the hypothesis that acupuncture intervention could produce the same
      therapeutic effects as antidepressants. The investigators also hypothesized that acupuncture
      would be associated with minimal side effects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim: To observe the curative effect of acupuncture in the treatment of Ischemic Post－Stroke
      Depression． Design: A multicentre,open-label randomized controlled trial will be performed in
      Tianjin and Beijing . Two hundred and eight participants with Ischemic Post-Stroke Depression
      patients were randomly divided into two groups which were both given basic treatment of
      stroke. The acupuncture group was given Tiaoshenkaiqiao acupuncture therapy and placebo，while
      the control group was treated with fluoxetine tablets and sham acupoint acupuncture
      treatment. Evaluated the clinical efficacy of the two groups with Hamilton Depression
      Scale(HAMD), Barthel Index (BI),Treatment Emergent Symptom Scale,(TESS ),Clinical Global
      Impression Scale(CGI) respectively before treatment, the second weekend of treatment ,the
      fourth weekend of treatment, the eighth weekend of treatment, the twelfth weekend of
      treatment. And observed the adverse reaction of the two groups.

      Each participants will receive 36 sessions of acupuncture in 12 weeks, with a duration of 30
      minutes in a session. After all the treatments were accomplished, there will be one
      follow-ups in the 24th week.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>17-item Hamilton Depression Scale( HAMD-17)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Depression symptoms are primarily measured using the 17-item Hamilton Depression Scale (HAMD-17)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Barthel Index (BI)</measure>
    <time_frame>12 weeks</time_frame>
    <description>physical outcomes will be measured using Barthel Index (BI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Global Impression (CGI)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Clinical Global Impression (CGI) would also be measured by clinician</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self-Rating Depression Scale(SDS)</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Emergent Symptom Scale,(TESS )</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke diagnosis and evaluation criteria of Traditional Chinese Medicine（TCM）</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Ratio of NAA/Cr，Cho/Cr，mI/Cr by Magnetic Resoance Spectroscopy(MRS)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Compare the ratio of NAA/Cr，Cho/Cr，mI/Cr in brain bilateral dorsolateral prefrontal, anterior cingulate alter brain metabolism after treatment.</description>
  </other_outcome>
  <other_outcome>
    <measure>Determination of the content change of cytokines IL-1β, IL-6, TNF-α, BDNF in plasma</measure>
    <time_frame>12 weeks</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">208</enrollment>
  <condition>Post-stroke Depression</condition>
  <arm_group>
    <arm_group_label>traditional acupuncture &amp; placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Apply traditional acupuncture to treat the ischemic post-stroke depression according to TCM theory.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham-acupoint acupuncture &amp; fluoxetine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fluoxetine was given at a dose of 20 mg/day. sham-acupoint will be penetrated for treat the ischemic post-stroke depression.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>acupuncture</intervention_name>
    <description>Patients will be treated at Renzhong（Du26）, Yintang（EX-HN3）、accupuncture Shangxing（DU23）penetrate to Baihui（DU20）,Sishencong（EX-HN1）; Neiguan（PC6）,Sibai（ST2）,Fengchi（GB20）and Sanyinjiao（SP6）in bilateral;Jianyu（LI15）,Quchi（LI11）,Shousanli（LI10）,Hegu（LI 4）, Fengshi (GB31),Xuehai（SP10） ,Zusanli（ST36）、Taichong（LR 3） of the hemiplegia side. There are another six groups of acupoints in bilateral. The acupuncturist will choose one group acupoints according to patients syndrome:Zhigou (SJ6),Qimen (LR14);Xingjian (LR2),Xiaxi(GB43);Fenglong (ST40),Lianquan(RN23);Tongli (HT5),Xinshu (BL15);Xinshu (BL15),Pishu(BL20);Shenshu (BL23),Taixi (KI3).
The acupoints are inserted at the depth of 20-30mm except Renzhong（Du26）, Sibai（ST2）, Sishencong（EX-HN1）are inserted at the depth of 5-10mm. The needles will be left for 30 minutes and then removed. Acupuncture treatment will consist of three sessions per week for 12 consecutive weeks.</description>
    <arm_group_label>traditional acupuncture &amp; placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Placebo was given for 12 consecutive weeks.</description>
    <arm_group_label>traditional acupuncture &amp; placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham-acupoint acupuncture</intervention_name>
    <description>Jianliao（SJ14）,Tianquan（PC2）,Xiabai (LU4),Xiaoluo (SJ12),Shouwuli (LI13),Sidu (SJ9),Huizong (SJ7),Wenliu (LI7),Zhouliao (LI12),Quze（PC3）,Kongzui（LI6）,Zhigou（SJ6）,Zhongzhu（SJ3）,Futu（ST32）,Jimen (SP11),Yinshi (ST33),Liangqiu（ST34）,Shangjuxu（ST37）,Xiajuxu（ST39）,Xiyangguan（GB33）,Ligou（LR5）,Pucan (BL61),Jinggu (BL64),Rangu (KI2),Ligou (LR5),Neiting （ST44） of the hemiplegia side.
• The acupoints are inserted at the depth of 20-30mm,except Pucan (BL61),Jinggu (BL64),Rangu (KI2) ,Neiting （ST44）are inserted at the depth of 5-10mm. The needles will be left for 30 minutes and then removed. Acupuncture treatment will consist of three sessions per week for 12 consecutive weeks.</description>
    <arm_group_label>sham-acupoint acupuncture &amp; fluoxetine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluoxetine</intervention_name>
    <description>Fluoxetine was given at a dose of 20 mg/day for12 consecutive weeks.</description>
    <arm_group_label>sham-acupoint acupuncture &amp; fluoxetine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  in accordance with diagnosis of ischemic stroke in International Classification of
             Diseases—10 163, （ICD-10 163）;

          -  diagnosis of a major depressive episode according to the depression module of the
             Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental
             Disorders-IV （DSM-IV）or Chinese Classification and Diagnostic Criteria of Mental
             Disorders-3(CCMD-3)

          -  age of a subject is between 40 and 80 years old, male or female;

          -  most recently experience an ischemic post-stroke depression and recent (&lt;6 months);

          -  conscious, examination cooperation, without aphasia and severe cognitive impairment;

          -  capacity to provide written consent for both research assessment and treatment.

        Exclusion Criteria:

          -  participation in any clinical trial within the previous or taking antidepressant
             treatment 2 weeks prior to baseline;

          -  presence of severe cognitive dysfunction, indicated the Mini-mental State Examination
             (MMSE) score of &lt; 17

          -  presence of severe aphasia;

          -  had a history of psychiatric illness or depression

          -  impaired hepatic , renal function., hematological systems and so on;

          -  those who can not cooperate with treatment;

          -  pregnant women or women in lactation

          -  presence of another chronic disorder, including chronic alcoholism or durg abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>First Affiliated hospital of Tianjin University of TCM</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <zip>300193</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Menghan Li, Master degree</last_name>
      <phone>13702120982</phone>
      <email>limenghan01@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Tao Sha, Master degree</last_name>
      <phone>13332056339</phone>
      <email>413927518@qq.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>First Affiliated Hospital of Tianjin University of TCM</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <zip>300193</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Menghan Li</last_name>
      <phone>13702120982</phone>
      <email>limenghan01@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tianjin Academy of Tradional Chinese Medicine Afflicated Hospital</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yang Yuanqing</last_name>
      <phone>13803081939</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing Hospital of Traditional Chinese Medicine</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wang linpeng</last_name>
      <email>wlp5558@sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 8, 2015</study_first_submitted>
  <study_first_submitted_qc>June 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2015</study_first_posted>
  <last_update_submitted>October 13, 2017</last_update_submitted>
  <last_update_submitted_qc>October 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Teaching Hospital of Tianjin University of Traditional Chinese Medicine</investigator_affiliation>
    <investigator_full_name>Prof Zhang Chunhong</investigator_full_name>
    <investigator_title>State Administration of Traditional Chinese Medicine of the People's Republic of China</investigator_title>
  </responsible_party>
  <keyword>Post－Stroke Depression</keyword>
  <keyword>Acupunture</keyword>
  <keyword>Fluoxetine</keyword>
  <keyword>RCT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluoxetine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

